Connecting Cardio & Cancer: Mitigating Cardiotoxicity with Optimized Treatment Strategies

By the year 2030, there will be around 22 million cancer survivors. And while cancer treatment continues to improve, it’s an unfortunate reality that many of these patients are at increased risk for cardiovascular issues, because of biology or as a byproduct of their life saving treatments. But recently, the field of cardio-oncology has emerged to help cancer patients minimize short and long term risks to their hearts. Dr. Stephanie Feldman speaks about the research pushing this innovative field forward and how it will increase the quality of life for so many patients in the years to come.